Differential effects of eprosartan and losartan at prejunctional angiotensin II receptors

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 363, Issue 5, 2001, Pages 509-514

  Guimaraes S ^a   Pinheiro, H ^a   Tavares, P ^a   Loio, A ^a   Moura, D ^a  

^a Institute of Pharmacology and Therapeutics   (Portugal)

Author keywords

Angiotensin II receptors; Canine pulmonary artery; Eprosartan; Losartan; PD123319; Rat ventricle

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; EPROSARTAN; LOSARTAN; NORADRENALIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; ELECTROSTIMULATION; NONHUMAN; NORADRENALIN RELEASE; POSTSYNAPTIC MEMBRANE; PULMONARY ARTERY; RAT; VASOCONSTRICTION;

ACRYLATES; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; FEMALE; HEART VENTRICLES; IMIDAZOLES; LOSARTAN; MALE; PRESYNAPTIC TERMINALS; PULMONARY ARTERY; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; THIOPHENES; VASOCONSTRICTOR AGENTS;

EID: 0035004930     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100100396     Document Type: Article

References (38)

1. Effect of losartan, a non-peptide angiotensin II receptor antagonist, on drinking behaviour and renal actions of centrally administered renin
2. Modulation of noradrenergic transmission in rat isolated trachea by angiotensin I and angiotensin II
3. Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype I receptors
4. Nomenclature for angiotensin receptors
5. Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist
6. In vitro pharmacology of DuP 753, a non-peptide AII receptor antagonist
7. Evidence for the involvement of different receptor subtypes in pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites
8. Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues
9. 1 receptor
10. Subclasses of angiotensin II binding sites and their functional significance
11. The discovery of DuP 753, a potent orally active non-peptide angiotensin II receptor antagonist
12. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SKF108566
13. Angiotensin II receptor subtypes in cultured rat renal mesangial cells
14. Effects of angiotensin II and angiotensin-(1-7) on the release of (3H) norepinephrine from rat atria
15. Adrenergic receptors in the veins of the dog
16. A study of the adrenoceptor-mediated feedback mechanisms by using adrenaline as a false transmitter
17. Different receptors for angiotensin II at pre- and postjunctional level of the canine mesenteric and pulmonary arteries
18. Action of natural angiotensin II and synthetic analogues on strips of rabbit aorta
19. Identification of two subtypes in the rat type 1 angiotensin II receptor
20. Involvement of angiotensin II receptors in the facilitatory effect of bradykinin on noradrenaline release from the rat left ventricle
21. Prejunctional effects of angiotensin II and bradykinin in the heart and blood vessels
22. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
23. Prejunctional receptors and second messengers for angiotensin II in the rabbit iris ciliary body
24. Inhibition of sympathetic outflow by angiotensin II receptor antagonists eprosartan, but not by losartan, valsartan or irbesartan: Relationship to differences in prejunctional angiotensin II receptor blockade
25. Renin-angiotensin system: Biochemistry and mechanisms of action
26. DuP 753 is a specific antagonist for the angiotensin receptor
27. β-adrenergic, angiotensin II, and bradykinin receptors enhance neurotransmission in human kidney
28. Differential inhibition of the pre-junctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan and losartan
29. Regulation of noradrenaline release by presynaptic receptor systems
30. Preferential blockade of presynaptic α-adrenoceptors by yohimbine
31. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on norepinephrine overflow and antidiuresis by stimulation of renal nerves in anesthetized dogs
32. Selective blockade of angiotensin responses in the rabbit isolated vas deferens by angiotensin receptor antagonists
33. Cumulative dose-response curves. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters
34. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands. DuP 753 (AII-1) and PD 123177 (AII-2)
35. In vivo pharmacology of DuP753
36. 1 receptor blockade and sympathoadrenal response to insulin-induced hypoglycemia in humans
37. A novel angiotensin receptor subtype in rat mesangium. Coupling to adenylyl cyclase
38. Effect of angiotensin and phenoxybenzamine on release of norepinephrine in vessels during sympathetic nerve stimulation